期刊文献+

丙酸氟替卡松与孟鲁司特治疗儿童轻度持续性哮喘疗效观察

下载PDF
导出
摘要 目的:观察吸入糖皮质激素丙酸氟替卡松或应用白三烯受体拮抗剂对儿童轻度持续性哮喘的防治作用。方法:将48例轻度持续性哮喘患儿随机分为治疗A组和治疗B组,每组24例,进行8周治疗,两组在常规治疗基础上,治疗A组给予丙酸氟替卡松气雾剂吸入,早晚各一次,每次一撳,治疗B组口服孟鲁司特4mg,每晚一次。8周的观察期内家长记录哮喘日记,包括白天、夜间症状评分、无症状天数及吸入β2-受体激动剂的次数等。结果:两组在治疗8周后患儿日夜间症状评分、无症状天数及吸入β2-受体激动剂的喷数均显著减少,无症状天数显著增加且无副作用。结论:吸入丙酸氟替卡松与应用白三烯受体拮抗剂治疗儿童轻度持续性哮喘均有较好疗效。
出处 《数理医药学杂志》 2012年第3期311-312,共2页 Journal of Mathematical Medicine
  • 相关文献

参考文献3

二级参考文献33

  • 1龚放,黄瑛,王路庆,邬萍,李茂霞.孟鲁司特治疗儿童支气管哮喘的临床疗效观察[J].小儿急救医学,2005,12(6):475-477. 被引量:38
  • 2李昌崇,林剑.儿童夜间哮喘[J].中国实用儿科杂志,2005,20(12):712-714. 被引量:31
  • 3Skoner DP. Balancing safety and efficacy in pediatric asthma management. Pediatrics, 2002, 109:381-392.
  • 4Brutsche MH, Brutsche IC, Munawar M, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomized crossover study. Lancet, 2000, 356:556-561.
  • 5Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc, 2004,1:315-320.
  • 6Thorsson L, Edsbacker S, Kallen A, et al. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br J Clin Pharmacol, 2001,52:529- 538.
  • 7Thorsson L, Edsbacker S, Conradson T-B. Lung deposition of budesonide from Turbnhaler is twice that from a pressurized metered-dose inhaler p-MDI. Eur Respir J, 1994, 7 : 1839-1844.
  • 8Kelly HW. Potential adverse effects of the inhaled corticosteroids. Jallergy Clin Immunol, 2003,112:469-478.
  • 9GINA executive committee. Global strategy for asthma management and prevention 2006. http://www, ginasthma, org/download, asp? intld = 217.
  • 10Kelly HW. Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids. Ann Allergy Asthma Immunol, 2003, 91:326-334.

共引文献2537

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部